Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PHARMACYCLICS GADOLITE MRI AGENT ENTERS PHASE III STUDIES

This article was originally published in The Gray Sheet

Executive Summary

PHARMACYCLICS GADOLITE MRI AGENT ENTERS PHASE III STUDIES for magnetic resonance imaging of the abdomen and pelvis, the firm announced Sept. 21. The multicenter trial, which is being conducted at 14 U.S. centers and one in Australia, will enroll 200 patients with "known or suspected abdominal and/or pelvic disease." To date, 15 patients have been enrolled in the trial; completion of the study is expected in early 1995, with a new drug application following in mid-1995.
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT002891

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel